Home > Financial Ratios > CONCORD BIOTECH

CONCORD BIOTECH
Core EBITDA Growth

    Back to All Ratios
CONCORD BIOTECH is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for CONCORD BIOTECH
Please provide your vote to see the results

CONCORD BIOTECH Last 5 Year Core EBITDA Growth History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Core EBITDA Growth(%) 18.3121.3829.11-12.9944.86

What is the latest Core EBITDA Growth ratio of CONCORD BIOTECH ?

The latest Core EBITDA Growth ratio of CONCORD BIOTECH is 18.31 based on Mar2025 Consolidated results.
Year Core EBITDA Growth
Mar202518.31
Mar202421.38
Mar202329.11
Mar2022-12.99
Mar202144.86

How is Core EBITDA Growth of CONCORD BIOTECH Trending?

Years Core EBITDA Growth % Change
Mar2025 18.31
-14.36
Mar2024 21.38
-26.55
Mar2023 29.11
Positive
Mar2022 -12.99
Negative
Mar2021 44.86 -

Other Financial Ratios of CONCORD BIOTECH


Compare Core EBITDA Growth ratio of peers of CONCORD BIOTECH

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
CONCORD BIOTECH ₹11,060.9 Cr 1% 2.3% -39.4% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹415,997.0 Cr 4.1% -1.3% -7.3% Stock Analytics
DIVIS LABORATORIES ₹171,900.0 Cr 3% 7.7% 7.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹142,804.0 Cr 2.1% 0.1% 26.8% Stock Analytics
DR REDDYS LABORATORIES ₹111,389.0 Cr 9.3% 6.6% 12% Stock Analytics
CIPLA ₹106,397.0 Cr 6.8% 7.7% -15.3% Stock Analytics


CONCORD BIOTECH Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
CONCORD BIOTECH

1%

2.3%

-39.4%

SENSEX

-1.6%

3.7%

-2.7%


You may also like the below Video Courses